Bernhard Kirschbaum

Bernhard Kirschbaum's current job(s) include being the Chairman at OMEICOS Therapeutics GmbH, an Independent Non-Executive Director at Redx Pharma Plc, a Director at BioMedx Group, Inc., a Scientific Advisor at FutuRx Ltd., a Member-Supervisory Board at BioMed X GmbH, and a Member-Supervisory Board at Amarna Therapeutics BV since 2019.
Dr. Kirschbaum's former job(s) include being the Chairman-Supervisory Board at Protagen AG, a Research Director at Merck Serono SA from 2005 to 2012, a Director at Enlivex Therapeutics Ltd., a Director at KAHR Medical Ltd., an Independent Director at Enlivex Therapeutics Ltd., a Principal at Institut Pasteur, a Principal at The Rockefeller University, and a Vice President-Discovery Research at Sanofi-Aventis Deutschland GmbH.
Dr. Kirschbaum obtained a doctorate degree from Universität Konstanz in 1989.